OSUR

Orasure Technologies

Stock NASDAQ – Stock Market Prices, News & Analysis

Orasure Technologies Inc. specializes in the development, manufacturing, and distribution of rapid diagnostic solutions and sample collection.

$ 3.08
0.98 %

Orasure Technologies

$ 3.08
0.98 %
OSUR

Orasure Technologies Inc. specializes in the development, manufacturing, and distribution of rapid diagnostic solutions and sample collection.

Price history of Orasure Technologies
Price history of Orasure Technologies

Performance & Momentum

6 Months 3.14 %
1 Year 4.35 %
3 Years 49.76 %
5 Years 70.44 %

Strategic Analysis

Orasure Technologies • 2026

Orasure Technologies positions itself as a specialist player in rapid diagnostics and sample collection, with a model focused on innovation in the healthcare and biotechnology sectors. Its niche relies on accessible and effective diagnostic solutions that meet the growing needs for rapid testing in clinical and non-laboratory settings.

Strengths
  • Recognized expertise in rapid diagnostics and sample collection
  • Presence in the U.S. market, with direct access to a dynamic healthcare sector
  • Integrated distribution that enhances control over the value chain
Weaknesses
  • Negative stock performance in the medium and long term amid intense competition
  • Lack of recent news catalysts that could revive investor interest
Momentum

Current momentum signals persistent selling pressure, reflecting a challenging context for the stock's valuation. This trend calls for caution, suggesting that investors should await signs of recovery based on product advancements or improvements in industry dynamics.

Analysis performed 1 month ago

Similar stocks to Orasure Technologies

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone